Related Experiment Videos
[Prenatal biopsychosocial risk and preeclampsia]
J A Herrera1, J P Alvarado, W Restrepo
1Universidade de Cali, Colombia.
Insights
Evaluating prenatal biopsychosocial risk (PBPSR) in pregnant women doubles the chance of identifying those who will develop arterial hypertension induced by pregnancy and pre-eclampsia (AHPP). This highlights the importance of comprehensive risk assessment for better maternal health outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Public Health
Context:
- Pregnancy-related hypertensive disorders, including pre-eclampsia, pose significant risks to maternal and fetal well-being.
- Prenatal care traditionally focuses on biomedical factors, often overlooking crucial psychosocial influences.
Purpose:
- To investigate the clinical presentation of arterial hypertension induced by pregnancy and pre-eclampsia (AHPP) in pregnant women exposed to prenatal biopsychosocial risk (PBPSR).
Summary:
- A prospective study of 1,076 pregnant women found that 6.4% developed AHPP.
- Women with AHPP were significantly more likely to have been exposed to high PBPSR (75.3%) compared to those with only biomedical risk factors (57.7%).
- High PBPSR was associated with an 8.5-fold increased risk of developing AHPP.
Impact:
- Integrating biopsychosocial risk assessment into routine prenatal care can significantly improve the early identification of pregnant women at high risk for AHPP.
- This approach can lead to timely interventions, potentially reducing the incidence and severity of AHPP and improving maternal and neonatal outcomes.
Objective:
To evaluate the clinical presentation of arterial hypertension induced by pregnancy and pre-eclampsia (AHPP) in patients exposed to prenatal biopsychosocial risk (PBPSR).
Design:
A prospective double-blind study.
Setting:
Primary Care. Four Health centres in Mendoza (Argentina), Cali and Popayán (Colombia) and Tegucicalpa (Honduras).
Patients:
1,076 pregnant women who were monitored from week 14 to 28 of pregnancy without there having been clinical evidence of pathology at the start.
Measurements And Main Results:
97 (9.9%) of the 1,076 pregnant women interviewed were withdrawn from the study because their records were incomplete or they had received therapy for psychosocial risk. Average age of the 979 pregnant women studied was 26.2 +/- 5.8. 339 (34.6%) were first carriers, 439 (44.9%) had a low social-economic level, 268 (27.3%) were exposed to high biopsychosocial risk and 69 (6.4%) developed AHPP. An evaluation of the patients with this condition found that 52 of these (75.3%) were exposed to high PBPSR [RR = 8.5, C.I. 95%, 4.5-15.9, p < 0.001], 22 (42.3%) displayed anxiety and/or poor family support during their pregnancy; and 30 (57.7%) were exposed only to biomedical risk factors [RR = 3.07, C.I. 95%, 1.96-4.82, p < 0.001].
Conclusions:
Whenever, as part of the evaluation of prenatal risk, the biopsychosocial risk is evaluated, the possibility of identifying pregnant patients who will develop AHPP doubles.